ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Elevance Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026
$430.23+1.97 (+0.46%)
Close on Oct 19, 2026
- Market cap
- $93.75B
- P/E (TTM)
- 19.1
- Dividend yield
- –
Share price
+$81.46 (+23.36%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
Elevance Health, Inc. grew revenue 6.3% to $201.11B over the twelve months to Jun 30, 2026. Operating income fell 29.0% to $5.45B, moving the operating margin from 4.1% to 2.7%. Free cash flow was $6.29B, up 17.8% from a year earlier.
Revenue
$201.11B
+6.3% vs. a year earlier
Operating income
$5.45B
-29.0% vs. a year earlier
Free cash flow
$6.29B
+17.8% vs. a year earlier
EPS, diluted
$22.50
-4.3% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $93.75B
- P/E ratio
- 19.1
- Price to sales
- 0.47
- Price to book
- 2.09
- Dividend yield
- –
- Free cash flow yield
- 6.71%
Fundamentals
- Revenue
- $201.11B
- Net income
- $4.96B
- EPS, diluted
- $22.50
- Free cash flow
- $6.29B
- Book value per share
- $205.98
- Diluted shares
- 218M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$201.11B+6.3% YoY
Gross profit
$179.26B+6.8% YoY
Operating income
$5.45B-29.0% YoY
Net income
$4.96B-7.4% YoY
EPS, diluted
$22.50-4.3% YoY
Free cash flow
$6.29B+17.8% YoY
Reported periodTrailing twelve months